Download PDF
Semin Plast Surg 2014; 28(02): 049-057
DOI: 10.1055/s-0034-1376260
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Vascular Tumors

Abel Sepulveda
1   Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
,
Edward P. Buchanan
1   Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
31 May 2014 (online)

Also available at
   Permissions and Reprints

Abstract

Vascular anomalies are divided into two main groups: tumors and malformations. Vascular tumors are a large and complex group of lesions, especially for clinicians with none or little experience in this field. In the past, these lesions caused a great deal of confusion because many appear analogous to the naked eye. Thankfully, recent advances in diagnostic techniques have helped the medical community to enhance our comprehension, accurately label, diagnose, and treat these lesions. In this article, we will review the most frequent vascular tumors and provide the reader with the tools to properly label, diagnose, and manage these complex lesions.

Keywords

vascular anomalies - vascular tumor - hemangioma - vascular malformation
 

  • References

  • 1 Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg 2011; 127 (1) 347-351
    CrossrefPubMedGoogle Scholar
  • 2 Burns AJ, Navarro JA, Cooner RD. Classification of vascular anomalies and the comprehensive treatment of hemangiomas. Plast Reconstr Surg 2009; 124 (1, Suppl) 69e-81e
    CrossrefPubMedGoogle Scholar
  • 3 Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg 2002; 110 (2) 572-585 , quiz 586, discussion 587–588
    CrossrefPubMedGoogle Scholar
  • 4 Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol 2012; 47 (2) 106-117
    CrossrefPubMedGoogle Scholar
  • 5 Arneja JS, Pappas PN, Shwayder TA , et al. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy. Plast Reconstr Surg 2010; 126 (3) 889-895
    CrossrefPubMedGoogle Scholar
  • 6 North PE. Pediatric vascular tumors and malformations. Surg Pathol 2010; 3: 455-494
    PubMedGoogle Scholar
  • 7 Maguiness SM, Frieden IJ . Vascular Birthmarks. In: L.A. Schachner & R. C. Hansen, eds. Pediatric Dermatology. 4 th ed. Philadelphia, PA: Mosby; 2011
  • 8 Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005; 32 (1) 99-116 , ix
    CrossrefPubMedGoogle Scholar
  • 9 Picard A, Boscolo E, Khan ZA , et al. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma. Pediatr Res 2008; 63 (3) 263-267
    CrossrefPubMedGoogle Scholar
  • 10 Barnés CM, Huang S, Kaipainen A , et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A 2005; 102 (52) 19097-19102
    CrossrefPubMedGoogle Scholar
  • 11 Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012; 2012: 645678
    PubMedGoogle Scholar
  • 12 Maguiness SM, Frieden IJ. Current management of infantile hemangiomas. Semin Cutan Med Surg 2010; 29 (2) 106-114
    CrossrefPubMedGoogle Scholar
  • 13 Chim H, Drolet B, Duffy K, Koshima I, Gosain AK. Vascular anomalies and lymphedema. Plast Reconstr Surg 2010; 126 (2) 55e-69e
    CrossrefPubMedGoogle Scholar
  • 14 Donnelly LF, Adams DM, Bisset III GS. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 2000; 174 (3) 597-608
    CrossrefPubMedGoogle Scholar
  • 15 Metry D, Heyer G, Hess C , et al; PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124 (5) 1447-1456
    CrossrefPubMedGoogle Scholar
  • 16 Coldwell DM, Baron RL, Charnsangavej C. Angiosarcoma. Diagnosis and clinical course. Acta Radiol 1989; 30 (6) 627-631
    CrossrefPubMedGoogle Scholar
  • 17 Fata F, O'Reilly E, Ilson D , et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86 (10) 2034-2037
    CrossrefPubMedGoogle Scholar
  • 18 Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol 2010; 11 (10) 983-991
    CrossrefPubMedGoogle Scholar